Buruli ulcer and mycolactone-producing mycobacteria

Japanese Journal of Infectious Diseases

Volumn 66, Issue 2, 2013, Pages 83-88

  Nakanaga, Kazue ^a   Yotsu, Rie Roselyne ^b   Hoshino, Yoshihiko ^a   Suzuki, Koichi ^a   Makino, Masahiko ^a   Ishii, Norihisa ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; MACROLIDE; MYCOLACTONE; NUCLEOTIDE; POLYKETIDE SYNTHASE; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

AFRICA SOUTH OF THE SAHARA; ARTICLE; ATYPICAL MYCOBACTERIUM; BURULI ULCER; CHINA; ENDEMIC DISEASE; HUMAN; JAPAN; LIMB; MYCOBACTERIUM; MYCOBACTERIUM ULCERANS; NONHUMAN; PLASMID; SUBSPECIES;

AFRICA SOUTH OF THE SAHARA; BURULI ULCER; CHINA; COMMUNICABLE DISEASES, EMERGING; HUMANS; JAPAN; MACROLIDES; MYCOBACTERIUM ULCERANS; PLASMIDS; POLYKETIDE SYNTHASES; VIRULENCE FACTORS;

EID: 84875324687     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.83     Document Type: Article

References (49)

1. Asiedu, K., Scherpbier, R., Raviglione, M., et al. (2000): Buruli ulcer: Mycobacterium ulcerans infection. In K. Asiedu, R. Scherpbier, and M. Raviglione (ed.). doc. No. WHO/CDS/CPE/GBUI/2000.1. World Health Organization, Geneva.
2. Pszolla, N., Sarkar, M.R., Strecker, W., et al. (2003): Buruli ulcer: a systemic disease. Clin. Infect. Dis., 37, e78-82.
3. Sizaire, V., Nackers, F., Comte, E., et al. (2006): Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect. Dis., 6, 288-296.
4. Portaels, F., Silva, M.T. and Meyers, W.M. (2009): Buruli ulcer. Clin. Dermatol., 27, 291-305.
5. Walsh, D.S., Portaels, F. and Meyers, W.M. (2011): Buruli ulcer: advances in understanding Mycobacterium ulcerans infection. Dermatol. Clin., 29, 1-8.
6. World Health Organization (2012): Buruli ulcer endemic countries (internet). Online at . Accessed December 5, 2012.
7. Mve-Obiang, A., Lee, R.E., Umstot, E.S., et al. (2005): A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect. Immun., 73, 3307-3312.
8. Ranger, B.S., Mahrous, E.A., Mosi, L., et al. (2006): Globally distributed mycobacterial fish pathogens produce a novel plasmidencoded toxic macrolide, mycolactone F. Infect. Immun., 74, 6037-6045.
9. Sakiguchi, K., Iimai H., Hirayama K., et al. (2011): Mycobacterium ulcerans infection in an indian flap-shelled turtle (Lissemys punctata punctata). J. Vet. Med. Sci., 73, 1217-1220.
10. Clancey, J.K., Dodge, O.G., Lunn, H.F., et al. (1961): Mycobacterial skin ulcers in Uganda. Lancet, 278, 951-954.
11. The Uganda Buruli Group (1971): Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans. R. Soc. Trop. Med. Hyg., 65,763-775.
12. Alsop, D.G. (1972): The Bairnsdale ulcer. Aust. NZ. J. Surg., 41, 317-319.
13. MacCallum, P., Tolhurst, J.C., Buckle, G., et al. (1948): A new mycobacterial infection in man. I. Clinical aspects. II. Experimental investigations in laboratory animals. III. Pathology of the experimental lesions in the rat. IV. Cultivation of the new mycobacterium. J. Pathol. Bacteriol., 60, 92-122.
14. Fenner, F. (1951): The significance of the incubation period in infectious diseases. Med. J. Austr., 2, 813-818.
15. Boyd, S.C., Athan, E., Friedman, N.D. et al. (2012): Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. Med. J. Aust., 196, 341-344.
16. Mikoshiba, H., Shindo, Y., Matsumoto, H., et al. (1982): A case of atypical mycobacteriosis due to Mycobacterium ulcerans-like organism. Nihon Hifukagakkaizassi, 92, 557-565 (in Japanese).
17. Tsukamura, M., Kaneda, K., Imaeda, T., et al. (1989): A taxonomic study on a mycobacterium which caused skin ulcer in a Japanese girl and resembled Mycobacterium ulcerans. Kekkaku, 64, 691-697 (in Japanese).
18. Kazumi, Y., Ohtomo, K., Takahashiet, M., et al. (2004): Mycobacterium shinshuense isolated from cutaneous ulcer lesion of right lower extremity in a 37-year-old woman. Kekkaku, 79, 437-441 (in Japanese).
19. Nakanaga, K., Ishii, N., Suzuki, K., et al. (2007): "Mycobacterium ulcerans subsp. shinshuense" isolated from a skin ulcer lesion: identification based on 16S rRNA gene sequencing. J. Clin. Microbiol., 45, 3840-3843.
20. Imada, H., Kishi, K., Okabe, T., et al. (2008): Cutaneous ulcer of a right olecranon due to Mycobacterium shinshuense; a case report. Seikeigeka, 59, 1440-1445 (in Japanese).
21. Suzuki, S., Arakawa, C., Shibuya, S., et al. (2008): Skin ulcer caused by 'Mycobacterium ulcerans subsp. shinshuense' infection. Hifubyou Shinryo, 30, 145-148 (in Japanese).
22. Kondo, M., Kurokawa, I., Ito, Y., et al. (2009): Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection. Int. J. Dermatol., 48, 1330-1333.
23. Funakoshi, T., Kazumi, Y., Okada, R., et al. (2009): Intractable ulcer caused by Mycobacterium shinshuense: successful identification of mycobacterium strain by 16S ribosomal RNA 3?-end sequencing. Clin. Exp. Dermatol., 34, e712-715.
24. Watanabe, T., Ohkusu, K., Nakanaga, K., et al. (2010): Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense. " Eur. J. Dermatol., 20, 809-810.
25. Matsumura, Y., Taki, R., Miyachi, Y., et al. (2012): Case of Buruli ulcer due to Mycobacterium ulcerans ssp. shinshuense with distal cutaneous involvement and synovitis. J. Dermatol., 39, 80-83.
26. Onoe, H., Yotsu, R.R., Nakanaga, K., et al. (2012): Buruli ulcer accompanied by pain in a Japanese patient. J. Dermatol., 39, 869-870.
27. Faber, W.R., Arias-Bouda, L.M., Zeegelaar, J.E., et al. (2000): First reported case of Mycobacterium ulcerans infection in a patient from China. Trans. R. Soc. Trop. Med. Hyg., 94, 277-279.
28. Nakanaga, K., Hoshino, Y., Yotsu, R.R., et al. (2011): Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010. J. Clin. Microbiol., 49, 3829-3836.
29. Yotsu, R.R., Nakanaga, K., Hoshino, Y., et al. (2012): Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection. J. Dermatol., 39, 587-593.
30. Read, J.K., Heggie, C.M., Meyers, W.M., et al. (1974): Cytotoxic activity of Mycobacterium ulcerans. Infect. Immun., 9, 1114-1122.
31. Hockmeyer, W.T., Krieg, R.E., Reich, M., et al. (1978): Further characterization of Mycobacterium ulcerans toxin. Infect. Immun., 21, 124-128.
32. Pimsler, M., Sponsler, T.A., Meyers, W.M. et al. (1988): Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans. J. Infect. Dis., 157, 577-580.
33. George, K.M., Chatterjee, D., Gunawardana, G., et al. (1999): Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science, 283, 854-857.
34. George, K.M., Pascopella, L., Welty, D.M., et al. (2000): Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect. Immun., 68, 877-883.
35. Mve-Obiang, A., Lee, R.E., Portaels, F., et al. (2003): Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect. Immun., 71, 774-783.
36. Kishi, Y. (2011): Chemistry of mycolactones, the causative toxins of Buruli ulcer. Proc. Natl. Acad. Sci. USA, 108, 6703-6708.
37. Stinear, T.P., Jenkin, G.A., Johnson, P.D., et al. (2000): Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence. J. Bacteriol., 182, 6322-6330.
38. Jenkin, G.A., Stinear, T.P., Johnson, P.D., et al. (2003): Subtractive hybridization reveals a type I polyketide synthase locus specific to Mycobacterium ulcerans. J. Bacteriol., 185, 6870-6882.
39. Stinear, T.P., Mve-Obiang, A., Small, P.L., et al. (2004): Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc. Natl. Acad. Sci. USA, 101, 1345-1349.
40. Stinear, T.P., Pryor, M.J., Porter, J.L., et al. (2005): Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans. Microbiology, 151, 683-692.
41. Goto, M., Nakanaga, K., Aung, T., et al. (2006): Nerve damage in Mycobacterium ulcerans-infected mice. Probable cause of painlessness in Buruli ulcer. Am. J. Pathol., 168, 805-811.
42. En, J., Goto, M., Nakanaga, K., et al. (2008): Mycolactone is responsible for the painlesness of Mycobacterium ulcerans infection (Buruli ulcer) in a murine study. Infect. Immun., 76, 2002-2007.
43. Coutanceau, E., Decalf, J., Martino, A. et al. (2007): Selective suppression of dendritic cell functions by Mycobacterium ulce rans toxin mycolactone. J. Exp. Med., 204, 1395-1403.
44. Trott, K.A., Stacy, B.A., Lifland, B.D., et al. (2004): Characterization of a Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs (Xenopus tropicalis). Comp. Med., 54, 309-317.
45. Chai, N., Bronchain, O., Panteix, G., et al. (2012): Propagation method of saving valuable strains from a Mycobacterium liflandii infection in Western clawed frogs (Silurana tropicalis). J. Zoo. Wildl. Med., 43, 15-19.
46. Nakanaga, K., Hoshino, Y., Hattori, Y., et al. (2012): Mycobacterium pseudoshottsii isolated from 24 farmed fishes in western Japan. J. Vet. Med. Sci., 74, 275-278.
47. Yip, M.J., Porter, J.L., Fyfe, J.A.M., et al. (2007): Evolution of Mycobacterium ulcerans and Other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J. Bacteriol., 189, 2021-2029.
48. Pidot, S.J., Hong, H., Seemann, T., et al. (2008): Deciphering the genetic basis for polyketide variation among mycobacteria producing mycolactones. BMC Genomics, 9, 462.
49. Pidot, S.J., Asiedu, K., Kaser, M., et al. (2010): Mycobacterium ulcerans and other mycolactone-producing mycobacteria should be considered a single species. PLoS Negl. Trop. Dis., 27, 4(7), e663.